Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.
about
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionLigand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements.LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway.Antiprogestins in gynecological diseases.Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells.The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancerActivation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer.Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells.Efficacy of DOPE/DC-cholesterol liposomes and GCPQ micelles as AZD6244 nanocarriers in a 3D colorectal cancer in vitro model.The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
P2860
Q29614274-D9531E02-0649-46EE-9311-095B131168EFQ31073908-D30EACDB-53DB-460A-A4C8-BCC8E55F31EFQ33708991-EBF85D4C-7492-4842-A7A4-F4DEBD33EA38Q34487171-FB5F5196-E157-4988-8321-8E22748A064EQ34587636-A1E3E87B-FB74-48C7-82BC-EA127FBA94D9Q35816378-1A1E9C26-B57D-4963-8D5B-053501C383D4Q35862359-05F84BE8-76B6-49FF-B5EB-1AC419BB595CQ36355880-A0B970A4-B119-41AA-8261-798E45ABD314Q37695410-3B39A92F-AF6B-4E44-89A8-ECABEA28E824Q38876630-BFF1ECA9-9233-4522-BF92-7A6F065648B9Q39425843-B0F33EFE-2B06-4FDB-8102-6B5142C0226DQ39513395-1C9748BB-098B-4BC9-AEFF-CA6A542D1FA5Q52888231-34FCFA0A-2AD8-417C-A60F-30EFC965841EQ55463049-01371EF6-B532-4009-A5BE-75141E17C00C
P2860
Responsiveness to PI3K and MEK inhibitors in breast cancer. Use of a 3D culture system to study pathways related to hormone independence in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Responsiveness to PI3K and MEK ...... hormone independence in mice.
@ast
Responsiveness to PI3K and MEK ...... hormone independence in mice.
@en
type
label
Responsiveness to PI3K and MEK ...... hormone independence in mice.
@ast
Responsiveness to PI3K and MEK ...... hormone independence in mice.
@en
prefLabel
Responsiveness to PI3K and MEK ...... hormone independence in mice.
@ast
Responsiveness to PI3K and MEK ...... hormone independence in mice.
@en
P2093
P2860
P1433
P1476
Responsiveness to PI3K and MEK ...... hormone independence in mice.
@en
P2093
Claudia Lanari
Maria Laura Polo
Maria Victoria Arnoni
Marina Riggio
Victoria Wargon
Virginia Novaro
P2860
P304
P356
10.1371/JOURNAL.PONE.0010786
P407
P577
2010-05-26T00:00:00Z